{"id":270,"date":"2025-12-05T05:20:50","date_gmt":"2025-12-05T05:20:50","guid":{"rendered":"https:\/\/www.lifescienceintellipedia.com\/blog\/?p=270"},"modified":"2025-12-05T05:20:51","modified_gmt":"2025-12-05T05:20:51","slug":"different-marketing-authorization-pathways-in-europe","status":"publish","type":"post","link":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/","title":{"rendered":"Different Marketing Authorization Pathways in Europe"},"content":{"rendered":"\n<p>Europe is one of the strictest <a href=\"https:\/\/www.lifescienceintellipedia.com\/resources.php\">pharma markets<\/a>, but also one of the best places to launch a new drug. Companies love the market size, but they also know the rules here can feel\u2026 well, a bit confusing.<\/p>\n\n\n\n<p>In Europe, drug approval does not happen through just one office. You have EMA, you have national authorities, and you even have multi-country routes that mix everything together. So if you\u2019re a company trying to enter the EU, it\u2019s easy to ask, <em>\u201cWhich pathway do I even use?\u201d<\/em> Don\u2019t worry, this blog keeps it super simple.<\/p>\n\n\n\n<p>In this post, we give a clear overview of the main marketing authorization pathways in Europe, when to use them, and why they matter. Whether you are planning a small local launch or a full EU-wide approval, you\u2019ll understand the basics without drowning in regulatory jargon.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What Is Marketing Authorization in Europe?<\/h2>\n\n\n\n<p>Marketing Authorization (MA) in Europe is basically the official permission a company needs before selling a medicine in the region. Without this approval, no drug can enter the market, simple as that. It\u2019s the EU\u2019s way of making sure every medicine is safe, effective, and high quality before patients ever use it.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Centralized Procedure (CP)<\/h2>\n\n\n\n<p>Instead of running around different countries, you file one application to the European Medicines Agency (EMA) and once it gets approved there, it\u2019s automatically approved in all EU member states at once.<\/p>\n\n\n\n<p>This pathway is mandatory for certain product types\u2014especially the high-tech stuff. If you\u2019re dealing with biologics, orphan drugs, advanced therapy medicinal products (ATMPs), cancer medicines, or new biotech products, you pretty much have no choice. The EU wants these handled under one roof.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Advantages of the Centralized Procedure<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Single Dossier:<\/strong> You don\u2019t prepare 27 versions of your application. Just one.<\/li>\n\n\n\n<li><strong>One Scientific Assessment:<\/strong> EMA\u2019s experts handle the review and issue one opinion.<\/li>\n\n\n\n<li><strong>EU-Wide Coverage:<\/strong> Approval applies to all EU countries automatically.<\/li>\n\n\n\n<li><strong>Consistent Labeling:<\/strong> Same product information everywhere\u2014no messy variations.<\/li>\n\n\n\n<li><strong>Strong Prestige:<\/strong> EMA approval boosts credibility globally.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Who Should Use the Centralized Procedure?<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Innovative pharma companies launching new, cutting-edge products<\/li>\n\n\n\n<li>Biotech firms with monoclonal antibodies, recombinant proteins, or ATMPs<\/li>\n\n\n\n<li>Companies with <a href=\"https:\/\/www.lifescienceintellipedia.com\/dossier-dmf.php\">orphan drugs<\/a> targeting rare diseases<\/li>\n\n\n\n<li>Oncology developers needing EU-wide access fast<\/li>\n\n\n\n<li>Any team that wants a single, clean regulatory pathway without juggling multiple national agencies<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Decentralized Procedure (DCP)<\/h2>\n\n\n\n<p>The Decentralized Procedure is basically for medicines that are not approved anywhere in Europe yet, but you still want to launch them in several countries at the same time. It\u2019s like doing a group project with a \u201cmain leader\u201d and a bunch of \u201cteam members.\u201d<\/p>\n\n\n\n<p>Here\u2019s a simple explanation of what happens under DCP:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>You pick one country to be the Reference Member State (RMS). This country does most of the scientific review.<\/li>\n\n\n\n<li>Then you choose other countries as Concerned Member States (CMS). They look at the RMS assessment and decide if they agree.<\/li>\n<\/ul>\n\n\n\n<p>This whole setup makes DCP perfect for medicines that are not brand-new inventions, but still need multi-country approval. Think generics, well-known active ingredients, or older drugs that need fresh approvals in the EU.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Mutual Recognition Procedure (MRP)<\/h2>\n\n\n\n<p>The Mutual Recognition Procedure is basically the \u201ccopy-paste\u201d route for Europe. You use it when your medicine is already approved in at least one EU country, and now you want other countries to accept that approval instead of starting from scratch.<\/p>\n\n\n\n<p>Here\u2019s the simple breakdown:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>You must already have a Marketing Authorization (MA) in one EU Member State.<br>This country becomes the Reference Member State (RMS).<\/li>\n\n\n\n<li>Other countries you want to enter become Concerned Member States (CMS).<br>They look at the RMS approval and basically say, \u201cOkay, we agree,\u201d unless they find serious concerns.<\/li>\n<\/ul>\n\n\n\n<p>This makes MRP a super practical route when your product is not new, not complicated, and already has a clean approval history.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What MRP is best for?<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Generic medicines that already proved their bioequivalence<\/li>\n\n\n\n<li>OTC products (simple formulations, low risk)<\/li>\n\n\n\n<li>Well-established active substances with a long safety record<\/li>\n\n\n\n<li>Companies expanding from one EU market to many, quickly and cheaply<\/li>\n<\/ul>\n\n\n\n<p>In short: MRP = one country approves first \u2192 others follow. Fast, simple, and great for scaling established products across Europe.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">National Procedure<\/h2>\n\n\n\n<p>The National Procedure is the most straightforward of all the European routes. You use it when you want to sell your medicine in just one country and nowhere else (at least for now). No cross-country coordination, no multi-state reviews\u2014just one national authority handling everything. This pathway is useful when your strategy is small, local, or still testing the market.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">When to&nbsp; use it?<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Single-country launches<\/strong> where you don\u2019t need EU-wide access<\/li>\n\n\n\n<li><strong>Simple products<\/strong> that don\u2019t require EMA involvement<\/li>\n\n\n\n<li><strong>Local sales strategies<\/strong>, such as focusing on one strong market first<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">How Major EU Markets Differ?<\/h3>\n\n\n\n<p>Each country has its own rules, timelines, and quirks (yes, it gets annoying):<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Germany<\/strong> \u2013 Fast reviews, very structured, strong generic market<\/li>\n\n\n\n<li><strong>France<\/strong> \u2013 More paperwork, heavy pricing controls<\/li>\n\n\n\n<li><strong>Spain<\/strong> \u2013 Slower timelines, but predictable once you understand the system<\/li>\n\n\n\n<li><strong>Italy<\/strong> \u2013 Additional administrative layers and price negotiations<\/li>\n<\/ul>\n\n\n\n<p>So even though it&#8217;s \u201cnational,\u201d each country plays by its own playbook.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Who This Route Works Well For<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Companies testing demand in one market before scaling up<\/li>\n\n\n\n<li>Firms with localized branding or distribution plans<\/li>\n\n\n\n<li>Products that are not eligible or not ready for DCP, MRP, or CP<\/li>\n<\/ul>\n\n\n\n<p>In short: <strong>National Procedure = simple, single-country approval without the EU-wide headache.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How Lifescience Intellipedia Helps Companies in EU Authorization?<\/h2>\n\n\n\n<p>Getting EU marketing authorization can feel confusing, but we make it simple. <a href=\"https:\/\/www.lifescienceintellipedia.com\/\">Lifescience Intellipedia<\/a> helps you pick the right pathway, prepare clean dossiers, and move through approvals without delays.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Smart RMS Selection<\/h3>\n\n\n\n<p>We help you choose an RMS that is fast, cooperative, and experienced with your product type, making the DCP\/MRP process smoother.<\/p>\n\n\n\n<p><strong>Strong, Fixed Dossiers<\/strong><\/p>\n\n\n\n<p>Our team checks your documents through a full gap analysis and helps you fix:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Country-specific Module 1<\/li>\n\n\n\n<li>Quality and safety sections<\/li>\n\n\n\n<li>Forms and product information<\/li>\n<\/ul>\n\n\n\n<p>This reduces objections and speeds up approval.<\/p>\n\n\n\n<p><strong>Full DCP\/MRP Support<\/strong><\/p>\n\n\n\n<p>We manage the entire process, including:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Application preparation<\/li>\n\n\n\n<li>Handling RMS\/CMS questions<\/li>\n\n\n\n<li>Coordinating responses and timelines<\/li>\n<\/ul>\n\n\n\n<p>You don\u2019t deal with the regulatory chaos, we do.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Europe is one of the strictest pharma markets, but also one of the best places to launch a new drug. Companies love the market size, but they also know the rules here can feel\u2026 well, a bit confusing. In Europe, drug approval does not happen through just one office. You have EMA, you have national [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":271,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[38,89,88],"class_list":["post-270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-research","tag-lifescience-intellipedia","tag-orphan-drugs","tag-pharma-markets"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Different Marketing Authorization Pathways in Europe - LifescienceIntellipedia<\/title>\n<meta name=\"description\" content=\"In this post, we give a clear overview of the main marketing authorization pathways in Europe, when to use them, and why they matter.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Different Marketing Authorization Pathways in Europe - LifescienceIntellipedia\" \/>\n<meta property=\"og:description\" content=\"In this post, we give a clear overview of the main marketing authorization pathways in Europe, when to use them, and why they matter.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"LifescienceIntellipedia\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-05T05:20:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-05T05:20:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-content\/uploads\/2025\/12\/Different-Marketing-Authorization-Pathways-in-Europe-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sandeep Patel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandeep Patel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/\",\"url\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/\",\"name\":\"Different Marketing Authorization Pathways in Europe - LifescienceIntellipedia\",\"isPartOf\":{\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-content\/uploads\/2025\/12\/Different-Marketing-Authorization-Pathways-in-Europe-1.jpg\",\"datePublished\":\"2025-12-05T05:20:50+00:00\",\"dateModified\":\"2025-12-05T05:20:51+00:00\",\"author\":{\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/#\/schema\/person\/dd40e842e0a65662e5ce1d2e9bc2ce00\"},\"description\":\"In this post, we give a clear overview of the main marketing authorization pathways in Europe, when to use them, and why they matter.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#primaryimage\",\"url\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-content\/uploads\/2025\/12\/Different-Marketing-Authorization-Pathways-in-Europe-1.jpg\",\"contentUrl\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-content\/uploads\/2025\/12\/Different-Marketing-Authorization-Pathways-in-Europe-1.jpg\",\"width\":700,\"height\":400,\"caption\":\"Different Marketing Authorization Pathways in Europe\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Different Marketing Authorization Pathways in Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/#website\",\"url\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/\",\"name\":\"Abhabio\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/#\/schema\/person\/dd40e842e0a65662e5ce1d2e9bc2ce00\",\"name\":\"Sandeep Patel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6615854e7daf09d53a423dfbf1993a5227d31f747ff30f155081414ce4096675?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6615854e7daf09d53a423dfbf1993a5227d31f747ff30f155081414ce4096675?s=96&d=mm&r=g\",\"caption\":\"Sandeep Patel\"},\"url\":\"https:\/\/www.lifescienceintellipedia.com\/blog\/author\/sandeep-patel\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Different Marketing Authorization Pathways in Europe - LifescienceIntellipedia","description":"In this post, we give a clear overview of the main marketing authorization pathways in Europe, when to use them, and why they matter.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/","og_locale":"en_US","og_type":"article","og_title":"Different Marketing Authorization Pathways in Europe - LifescienceIntellipedia","og_description":"In this post, we give a clear overview of the main marketing authorization pathways in Europe, when to use them, and why they matter.","og_url":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/","og_site_name":"LifescienceIntellipedia","article_published_time":"2025-12-05T05:20:50+00:00","article_modified_time":"2025-12-05T05:20:51+00:00","og_image":[{"width":700,"height":400,"url":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-content\/uploads\/2025\/12\/Different-Marketing-Authorization-Pathways-in-Europe-1.jpg","type":"image\/jpeg"}],"author":"Sandeep Patel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sandeep Patel","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/","url":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/","name":"Different Marketing Authorization Pathways in Europe - LifescienceIntellipedia","isPartOf":{"@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#primaryimage"},"image":{"@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-content\/uploads\/2025\/12\/Different-Marketing-Authorization-Pathways-in-Europe-1.jpg","datePublished":"2025-12-05T05:20:50+00:00","dateModified":"2025-12-05T05:20:51+00:00","author":{"@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/#\/schema\/person\/dd40e842e0a65662e5ce1d2e9bc2ce00"},"description":"In this post, we give a clear overview of the main marketing authorization pathways in Europe, when to use them, and why they matter.","breadcrumb":{"@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#primaryimage","url":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-content\/uploads\/2025\/12\/Different-Marketing-Authorization-Pathways-in-Europe-1.jpg","contentUrl":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-content\/uploads\/2025\/12\/Different-Marketing-Authorization-Pathways-in-Europe-1.jpg","width":700,"height":400,"caption":"Different Marketing Authorization Pathways in Europe"},{"@type":"BreadcrumbList","@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/different-marketing-authorization-pathways-in-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lifescienceintellipedia.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Different Marketing Authorization Pathways in Europe"}]},{"@type":"WebSite","@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/#website","url":"https:\/\/www.lifescienceintellipedia.com\/blog\/","name":"Abhabio","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lifescienceintellipedia.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/#\/schema\/person\/dd40e842e0a65662e5ce1d2e9bc2ce00","name":"Sandeep Patel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.lifescienceintellipedia.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6615854e7daf09d53a423dfbf1993a5227d31f747ff30f155081414ce4096675?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6615854e7daf09d53a423dfbf1993a5227d31f747ff30f155081414ce4096675?s=96&d=mm&r=g","caption":"Sandeep Patel"},"url":"https:\/\/www.lifescienceintellipedia.com\/blog\/author\/sandeep-patel\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/posts\/270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/comments?post=270"}],"version-history":[{"count":1,"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/posts\/270\/revisions"}],"predecessor-version":[{"id":272,"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/posts\/270\/revisions\/272"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/media\/271"}],"wp:attachment":[{"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/media?parent=270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/categories?post=270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lifescienceintellipedia.com\/blog\/wp-json\/wp\/v2\/tags?post=270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}